News

Strategies for Improving Patient-Centric Care in Cannabis Use

Strategies for Improving Patient-Centric Care in Cannabis Use

Understanding Cannabis Patient-Centric Care

During a recent conference, leaders in the cannabis industry came together to discuss vital strategies for improving patient-centric care. As regulatory hurdles and market dynamics evolve, prioritizing patient education and accessibility in medical cannabis becomes essential.

Facing Accessibility Challenges

Dr. Christina Betancourt Johnson, CEO of The Forest by Standard Wellness, emphasized the significance of engaging with lawmakers to advocate for patient rights. She noted that even as adult-use cannabis rises, maintaining medical access is critical. Educational efforts are necessary as many legislators may lack familiarity with cannabis.

Building Relationships for Advocacy

Johnson's company operates in several states and highlights the importance of creating relationships with elected officials well before entering new markets. She promotes tax incentives for medical patients and calls for dedicated shelf space for medical products.

Navigating Complexity in Market Segments

Emily Fisher, founder of Leafwell, highlighted the friction introduced by the adult-use market, which can hinder therapeutic access for patients. Leafwell focuses on educating potential users, making sure those in need of therapeutic benefits understand their options.

Identifying Patient Needs

As new consumers enter the market seeking therapeutic relief, many do not possess medical cards due to existing barriers. Leafwell has established the largest integrated clinic network, facilitating access across various regions where both medical and adult-use cannabis are available.

Preserving Medical Integrity

Tim Pickett, CEO of Kindly MD (NASDAQ: KDLY), shared concerns regarding the shift in focus toward adult-use sales. He stressed that this could undermine the recognition of cannabis as a legitimate medicine, potentially sidelining therapeutic users who rely on cannabis for health reasons.

Long-Term Considerations for Investors

As recreational sales increase, investors should not overlook the substantial market for medical cannabis. Pickett emphasizes the need to view cannabis through the lens of its health benefits rather than solely as a recreational substance.

Exploring Broader Perspectives on Health

Ricky Williams, notable for his NFL career and founder of Highsman, dedicated a segment to examining how different societal sectors view cannabis. He pointed out that while athletes might have unique health perspectives, there remains a lack of understanding among the general public regarding the therapeutic potentials of cannabis.

Encouraging Open Conversations

By encouraging dialogue around therapeutic cannabis, consumers can become more aware of its potential benefits. A necessary distinction exists between medical and therapeutic cannabis, offering a broader understanding of its uses beyond just recreational applications.

Addressing Confusion Around Registration

The discussions revealed confusion about medical cannabis registration, particularly regarding how it might affect government benefits. Participants noted that differing state regulations only worsen this uncertainty.

Clarifying Cannabis Regulations for Better Access

Dr. Betancourt Johnson concluded that clearer communication from advocates and regulators could significantly improve patient rights and knowledge about the cannabis landscape, and help reduce confusion surrounding registration.

Future Directions in Cannabis Wellness

The panel emphasized that with proper advocacy and education, there exists a considerable opportunity to enhance the wellness cannabis market. By continuing to focus on patient needs and addressing the barriers in access, the industry can foster an environment where therapeutic cannabis achieves the recognition and legitimacy it deserves.

Frequently Asked Questions

What is patient-centric care in cannabis?

Patient-centric care in cannabis focuses on ensuring that individuals receive the right information and support for their therapeutic needs while navigating the cannabis market.

Who are the key speakers in the cannabis care discussions?

Notable speakers included Dr. Christina Betancourt Johnson, Emily Fisher, Tim Pickett, and Ricky Williams, each bringing valuable insights to the table.

What challenges do patients face in accessing cannabis?

Patients often encounter regulatory hurdles, confusion about medical vs. adult-use options, and complexities in obtaining necessary medical cards.

How can cannabis education help consumers?

Education can empower consumers by providing them with knowledge about therapeutic uses, helping them to navigate the market effectively and make informed choices.

What is the significance of advocating for medical cannabis?

Advocacy is essential to ensure the sustainability and recognition of medical cannabis as an important treatment option, emphasizing its therapeutic benefits over recreational use.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Zenas BioPharma Investors Urged to Join Class Action Lawsuit

Updated Category News Views 119

Overview of the Class Action Lawsuit Levi & Korsinsky, LLP is reaching out to investors in Zenas BioPharma, Inc. regarding a crucial class action lawsuit. This lawsuit may greatly impact those who have invested in Zenas BioPharma as it seeks to compensate individuals who have suffered losses due to alleged securities fraud. Understanding the Legal Landscape This class...

Continue Reading
Ayar Labs Raises $155 Million to Transform AI Infrastructure

Updated Category News Views 716

Ayar Labs Secures Significant Funding to Enhance AI Infrastructure Ayar Labs has recently secured $155 million in financing aimed at addressing the critical needs in AI infrastructure. With backing from prominent investors such as AMD Ventures, Intel Capital, and NVIDIA, alongside Advent Global Opportunities and Light Street Capital, this investment elevates the total...

Continue Reading
Transforming the Non-Profit Sector: The Impact Collaborative

Updated Category News Views 159

Impact Collaborative Launches to Transform the Non-Profit Sector Today marks a significant milestone with the launch of the Impact Collaborative (IC), a pioneering initiative aimed at revolutionizing the support provided to under-resourced communities. This innovative approach seeks to disrupt generational poverty while offering much-needed access to mental health and...

Continue Reading
Synovus Financial Corp Declares Quarterly Dividends for Investors

Updated Category News Views 128

Synovus Financial Corp Declares Quarterly Dividends Synovus Financial Corp. (NYSE: SNV) has recently revealed the details of its latest quarterly dividends. The board of directors has approved significant payouts to its shareholders, reinforcing the company’s ongoing commitment to deliver value to its investors. Details of the Declared Dividends The following dividends...

Continue Reading
Walnut Hill Medical Enhances Patient Access Through FDA TAP Program

Updated Category News Views 171

Walnut Hill Medical Partners with FDA in TAP Program Walnut Hill Medical, a prominent healthcare consultancy known for its market access and reimbursement strategies, has been chosen as an advisor to the FDA's Total Product Life Cycle Advisory Program (TAP). This initiative, which originated from the FDA's Center for Devices and Radiological Health (CDRH), aims to improve...

Continue Reading